한글목차

B형 간염 치료제 시장은 2023-2028년 4억 6,950만 달러 규모, 예측 기간 동안 3.27%의 CAGR로 성장할 것으로 예상됩니다.

본 보고서는 B형 간염 치료제 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 포함한 벤더 분석 등의 정보를 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 영유아의 B형 간염 유병률 증가, B형 간염에 대한 인식 개선 이니셔티브 증가, HBV(B형 간염 바이러스) 분자진단에 대한 수요 증가에 의해 주도되고 있습니다.

이 보고서는 향후 몇 년 동안 B형 간염 치료제 시장 성장을 주도할 주요 요인 중 하나로 신기술의 발전을 꼽았습니다. 또한 강력한 파이프라인, HBV 진단 검사에 대한 인식 증가 및 선별 검사 프로그램 증가는 시장의 큰 수요로 이어질 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 상황

• 시장 생태계
• 시장 특징
• 밸류체인 분석

제3장 시장 규모 평가

• 시장 정의
• 시장 부문 분석
• 시장 규모 2023
• 시장 전망 2023-2028

제4장 시장 규모 실적

• 세계 B형 간염 치료제 시장 2018-2022
• 용도별 부문 분석 2018-2022
• 지역별 부문 분석 2018-2022
• 국가별 부문 분석 2018-2022

제5장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제6장 시장 세분화 : 용도별

• 시장 세분화
• 비교 : 용도별
• 약품 : 시장 규모와 예측 2023-2028
• 백신 : 시장 규모와 예측 2023-2028
• 시장 기회 : 용도별

제7장 고객 상황

• 고객 상황 개요

제8장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측 2023-2028
• 유럽 : 시장 규모와 예측 2023-2028
• 아시아 : 시장 규모와 예측 2023-2028
• 세계 기타 지역 : 시장 규모와 예측 2023-2028
• 미국 : 시장 규모와 예측 2023-2028
• 독일 : 시장 규모와 예측 2023-2028
• 멕시코 : 시장 규모와 예측 2023-2028
• 중국 : 시장 규모와 예측 2023-2028
• 브라질 : 시장 규모와 예측 2023-2028
• 시장 기회 : 지역 상황별

제9장 촉진요인, 과제, 기회, 억제요인

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회·억제요인

제10장 경쟁 상황

• 개요
• 경쟁 상황
• 혼란 상황
• 업계 리스크

제11장 경쟁 분석

• 기업 개요
• 기업의 시장 포지셔닝
• Biotest AG
• Bristol Myers Squibb Co.
• Dynavax Technologies Corp.
• Emergent BioSolutions Inc.
• F. Hoffmann La Roche Ltd.
• Gilead Sciences Inc.
• GlaxoSmithKline Plc
• Merck and Co. Inc.
• Novartis AG
• Viatris Inc.

제12장 부록

영문목차

The hepatitis B therapeutics market is forecasted to grow by USD 469.5 mn during 2023-2028, accelerating at a CAGR of 3.27% during the forecast period. The report on the hepatitis B therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of hepatitis B infants, growing initiatives to increase awareness about hepatitis B, and growing demand for molecular diagnostics of hbv.

Technavio's hepatitis B therapeutics market is segmented as below:

By Application

• Drugs
• Vaccines

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the new technological advancements as one of the prime reasons driving the hepatitis B therapeutics market growth during the next few years. Also, strong pipeline and increasing awareness and screening programs of hbv diagnostic tests will lead to sizable demand in the market.

The report on the hepatitis B therapeutics market covers the following areas:

• Hepatitis B therapeutics market sizing
• Hepatitis B therapeutics market forecast
• Hepatitis B therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hepatitis B therapeutics market vendors that include Biotest AG, Bristol Myers Squibb Co., CASI Pharmaceuticals Inc., Cipla Inc., Dynavax Technologies Corp., Emergent BioSolutions Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline PLC, Hetero Healthcare Ltd., Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the hepatitis B therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Hepatitis B Therapeutics Market 2018 - 2022
  • Historic Market Size - Data Table on Global Hepatitis B Therapeutics Market 2018 - 2022 ($ million)
• 4.2 Application segment analysis 2018 - 2022
  • Historic Market Size - Application Segment 2018 - 2022 ($ million)
• 4.3 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.4 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

• 6.1 Market segments
  • Chart on Application - Market share 2023-2028 (%)
  • Data Table on Application - Market share 2023-2028 (%)
• 6.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
• 6.3 Drugs - Market size and forecast 2023-2028
  • Chart on Drugs - Market size and forecast 2023-2028 ($ million)
  • Data Table on Drugs - Market size and forecast 2023-2028 ($ million)
  • Chart on Drugs - Year-over-year growth 2023-2028 (%)
  • Data Table on Drugs - Year-over-year growth 2023-2028 (%)
• 6.4 Vaccines - Market size and forecast 2023-2028
  • Chart on Vaccines - Market size and forecast 2023-2028 ($ million)
  • Data Table on Vaccines - Market size and forecast 2023-2028 ($ million)
  • Chart on Vaccines - Year-over-year growth 2023-2028 (%)
  • Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)

7 Customer Landscape

• 7.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

• 8.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 8.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 8.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 8.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 8.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 8.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 8.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 8.9 Mexico - Market size and forecast 2023-2028
  • Chart on Mexico - Market size and forecast 2023-2028 ($ million)
  • Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
  • Chart on Mexico - Year-over-year growth 2023-2028 (%)
  • Data Table on Mexico - Year-over-year growth 2023-2028 (%)
• 8.10 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 8.11 Brazil - Market size and forecast 2023-2028
  • Chart on Brazil - Market size and forecast 2023-2028 ($ million)
  • Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
  • Chart on Brazil - Year-over-year growth 2023-2028 (%)
  • Data Table on Brazil - Year-over-year growth 2023-2028 (%)
• 8.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

• 9.1 Market drivers
• 9.2 Market challenges
• 9.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 9.4 Market opportunities/restraints

10 Competitive Landscape

• 10.1 Overview
• 10.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 10.3 Landscape disruption
  • Overview on factors of disruption
• 10.4 Industry risks
  • Impact of key risks on business

11 Competitive Analysis

• 11.1 Companies profiled
  • Companies covered
• 11.2 Market positioning of companies
  • Matrix on companies position and classification
• 11.3 Biotest AG
  • Biotest AG - Overview
  • Biotest AG - Business segments
  • Biotest AG - Key offerings
  • Biotest AG - Segment focus
• 11.4 Bristol Myers Squibb Co.
  • Bristol Myers Squibb Co. - Overview
  • Bristol Myers Squibb Co. - Product / Service
  • Bristol Myers Squibb Co. - Key news
  • Bristol Myers Squibb Co. - Key offerings
• 11.5 Dynavax Technologies Corp.
  • Dynavax Technologies Corp. - Overview
  • Dynavax Technologies Corp. - Product / Service
  • Dynavax Technologies Corp. - Key offerings
• 11.6 Emergent BioSolutions Inc.
  • Emergent BioSolutions Inc. - Overview
  • Emergent BioSolutions Inc. - Product / Service
  • Emergent BioSolutions Inc. - Key offerings
• 11.7 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
• 11.8 Gilead Sciences Inc.
  • Gilead Sciences Inc. - Overview
  • Gilead Sciences Inc. - Product / Service
  • Gilead Sciences Inc. - Key news
  • Gilead Sciences Inc. - Key offerings
• 11.9 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
• 11.10 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
• 11.11 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
• 11.12 Viatris Inc.
  • Viatris Inc. - Overview
  • Viatris Inc. - Business segments
  • Viatris Inc. - Key news
  • Viatris Inc. - Key offerings
  • Viatris Inc. - Segment focus

12 Appendix

• 12.1 Scope of the report
• 12.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 12.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 12.4 Research methodology
  • Research methodology
• 12.5 Data procurement
  • Information sources
• 12.6 Data validation
  • Data validation
• 12.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 12.8 Data synthesis
  • Data synthesis
• 12.9 360 degree market analysis
  • 360 degree market analysis
• 12.10 List of abbreviations
  • List of abbreviations